AZ Delta (Campus Wilgenstraat)
About AZ Delta (Campus Wilgenstraat)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Apellis Pharmaceuticals, Inc.
1
Galapagos NV
1
Madrigal Pharmaceuticals, Inc.
1
Ottawa Heart Institute Research Corporation
1
PharmaMar
1
Seagen Inc.
1
Urovant Sciences GmbH
1
Clinical Trials at AZ Delta (Campus Wilgenstraat)
During the past decade, AZ Delta (Campus Wilgenstraat) conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia
2008-06-30
2009-12-31
Completed
35
A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)
2008-12-12
2017-07-27
Completed
2,825
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
2009-06-29
2015-09-09
Completed
921
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy
2012-07-31
2014-12-12
Completed
71
A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment
2013-06-20
2017-10-27
Completed
138
Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
2016-01-01
2025-08-01
Active, not recruiting
1,284
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer
2016-08-30
2020-02-24
Completed
613
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "AZ Delta (Campus Wilgenstraat)" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Apellis Pharmaceuticals, Inc." with 1 trials
sponsored, "Galapagos NV" with 1 trials sponsored, "Madrigal Pharmaceuticals, Inc." with 1 trials sponsored and "Ottawa Heart Institute Research Corporation"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Delta (Campus Wilgenstraat)"
#1 collaborator was "Bayer" with 1 trials as a collaborator, "Biotronik Canada Inc" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at AZ Delta (Campus Wilgenstraat)
According to Clinical.Site data, the most researched conditions in "AZ Delta (Campus Wilgenstraat)" are
"Acute Myeloid Leukemia" (1 trials), "Anemia" (1 trials), "Atrial Fibrillation" (1 trials), "Breast Cancer" (1 trials) and "Chronic Renal Anemia" (1 trials). Many other conditions were trialed in "AZ Delta (Campus Wilgenstraat)" in a lesser frequency.
Clinical Trials Intervention Types at AZ Delta (Campus Wilgenstraat)
Most popular intervention types in "AZ Delta (Campus Wilgenstraat)" are "Drug" (14 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "methoxy polyethylene glycol-epoetin beta" (2 trials), "33A" (1 trials), "Acetylsalicylic acid" (1 trials) and "Alectinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AZ Delta (Campus Wilgenstraat)
The vast majority of trials in "AZ Delta (Campus Wilgenstraat)" are
14 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at AZ Delta (Campus Wilgenstraat)
Currently, there are NaN active trials in "AZ Delta (Campus Wilgenstraat)".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in AZ Delta (Campus Wilgenstraat),
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in AZ Delta (Campus Wilgenstraat), 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".